Metropolitan Life Insurance Company (MetLife)’s BlueLinx BXC Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BXC Stock Details BXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-432	Closed	-$56.3K	–	343
2024 Q1	$56.3K	Sell	432 -58	-12%	-$6.82K	﹤0.01%	1345
2023 Q4	$55.5K	Hold	490	–	–	﹤0.01%	1392
2023 Q3	$40.2K	Buy	490 +38	+8%	+$3.34K	﹤0.01%	1525
2023 Q2	$42.4K	Sell	452 -71	-14%	-$5.67K	﹤0.01%	1520
2023 Q1	$35.5K	Hold	523	–	–	﹤0.01%	1576
2022 Q4	$37.2K	Sell	523 -104	-17%	-$7.09K	﹤0.01%	1653
2022 Q3	$38.9K	Hold	627	–	–	﹤0.01%	1623
2022 Q2	$41.9K	Hold	627	–	–	﹤0.01%	1611
2022 Q1	$45.1K	Sell	627 -2,032	-76%	-$166K	﹤0.01%	1655
2021 Q4	$255K	Hold	2,659	–	–	﹤0.01%	1851
2021 Q3	$130K	Hold	2,659	–	–	﹤0.01%	2371
2021 Q2	$134K	Buy	+2,659	New	+$131K	﹤0.01%	2430
2019 Q4	–	Sell	-3,079	Closed	-$99.5K	–	2539
2019 Q3	$99.5K	Buy	+3,079	New	+$77.7K	﹤0.01%	2308
2018 Q4	–	Sell	-3,156	Closed	-$99.4K	–	2551
2018 Q3	$99.4K	Hold	3,156	–	–	﹤0.01%	2458
2018 Q2	$118K	Buy	+3,156	New	+$123K	﹤0.01%	2236

Other funds holding BXC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

JCP

JB Capital Partners Armonk, New York $646M AUM 39.9% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BXC Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of BlueLinx (BXC) in Q2 2024, closing a stake of 432 shares — an estimated $56.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BXC in Q2 2018 and held it in 15 quarters. The position peaked at $255K in Q4 2021. 168 funds tracked by Wall St. Rank hold BXC as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining BlueLinx position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 432 BlueLinx shares in Q2 2024, an estimated $56.3K.
Metropolitan Life Insurance Company (MetLife) first reported a position in BlueLinx in Q2 2018 and held it in 15 quarters.
Metropolitan Life Insurance Company (MetLife)'s BlueLinx position peaked at $255K in Q4 2021.
168 funds tracked by Wall St. Rank held BlueLinx as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.